Biomarker Discovery with Autoantibodies

September 13, 2023

Learn how to accelerate biomarker discovery with autoantibodies HERE

Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.

Design and development by RainCastle Communications.

Biomarker Discovery with Autoantibodies

Fill in the form to download the publication

Watch the video

Watch the video

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation

Read the Review

Watch the video